- $1.37bn
- $1.33bn
- $1.19bn
- 65
- 82
- 74
- 86
REG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Holding(s) in Company
AnnouncementREG - Indivior PLC - Holding(s) in Company
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Further Changes to Board of Directors
AnnouncementREG - Indivior PLC - Indivior PLC Files 2024 Annual Report on Form 10-K
AnnouncementREG - Indivior PLC - Total Voting Rights
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC Morgan Stanley - Holding(s) in Company
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Joseph Ciaffoni Appointed Chief Executive Officer
AnnouncementREG - Indivior PLC Morgan Stanley - Holding(s) in Company
AnnouncementREG - Indivior PLC - FDA Approval of SUBLOCADE Label Changes
AnnouncementREG - Indivior PLC - Final Results
AnnouncementREG - Indivior PLC - Delayed FDA Approval of SUBLOCADE Label Changes
AnnouncementREG - Indivior PLC - Notice of Results
Announcement